RFP
RGNX icon

Root Financial Partners’s Regenxbio RGNX Stock Holding History

Root Financial Partners’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.69K Buy
+202
New +$2.12K ﹤0.01% 2387

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Root Financial Partners's RGNX Position: Q1 2026 in Review

Root Financial Partners opened a new position in Regenxbio (RGNX) in Q1 2026: 202 shares worth $1.69K. The stake represents ﹤0.01% of the portfolio and ranks #2387 among its holdings.

178 funds tracked by Wall St. Rank hold RGNX as of Q1 2026.

  • Root Financial Partners held 202 shares of Regenxbio worth $1.69K as of Q1 2026.
  • Regenxbio was a new Root Financial Partners position in Q1 2026.
  • Regenxbio made up ﹤0.01% of Root Financial Partners's portfolio in Q1 2026, its #2387 holding.
  • 178 funds tracked by Wall St. Rank held Regenxbio as of Q1 2026.

Based on Root Financial Partners's 13F filing for Q1 2026, filed 24 Apr 2026.